Level C· Early human research exploring benefitsRetrospective StudyEurope PMC

Application of bone perforation in the surgery of medication-related osteonecrosis of the jaw in stage Ⅱ

Gao N., Tian M., Sun Y., Wang D., Sun G.

Retrospective Study with a reported sample of 21 on Face & Skin, published in Hua Xi Kou Qiang Yi Xue Za Zhi (2024) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Retrospective Study
Journal
Hua Xi Kou Qiang Yi Xue Za Zhi (2024)
Reported sample size
21
Source database
Europe PMC
PMID
39304506
PMCID
PMC11493859
DOI
10.7518/hxkq.2024.2024133

Abstract (original English)

Objectives This study aimed to explore the effect of surgery combined with bone perforation for treating stage Ⅱ medication-related osteonecrosis of the jaw (MRONJ). Methods A total of 21 patients with stage Ⅱ mandibular MRONJ who underwent surgical treatment from June 2020 to June 2023 were included in this study. Retrospective analysis was conducted on their clinical data, including gender, age, primary disease, drug name and administration method, pre-surgery drug cessation, and prognosis. The cohort comprised 14 males and 7 females, with an average age at onset of 68.33±10.74 years. According to the guidelines of the American Association of Oral and Maxillofacial Surgeons, the included patients had stage Ⅱ mandibular MRONJ. The treatment approach consisted of partial mandibulectomy combined with bone perforation techniques, ensuring tension-free suturing of soft tissues. Follow-up was performed regularly, and the curative effect was evaluated. The SF-12 health survey was used to assess the quality of life for all patients before and after surgery. Results A total of 21 patients were followed up for 8-38 months after surgery, and the mucosal healing of 17 patients was good (80.95%). The postoperative quality of life score (83.62±5.90) was significantly higher than that before operation (63.67±4.70, P Conclusions Surgery combined with bone perforation te-chnique is an effecti

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
MandibleHumansRetrospective StudiesQuality of LifeAgedMiddle AgedFemaleMaleBisphosphonate-Associated Osteonecrosis of the Jaw

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research